Kohana Pharmacy and Center for Regenerative Medicine Inc.

Form 483 issued April 17, 2019 · San Luis Obispo, California

Inspection
Apr 10 – Apr 17, 2019
Observations
2
Pages
2
FEI number
3013501947

In short: On April 17, 2019, FDA issued a Form 483 with 2 observations to Kohana Pharmacy and Center for Regenerative Medicine Inc. in San Luis Obispo, California (FEI 3013501947) after an inspection that ran Apr 10 – Apr 17, 2019. The investigator was Uttaniti Limchumroon. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.67 (equipment cleaning and maintenance).

At a glance

Observations span 1 system, led by facilities & equipment.

Facilities & equipment1
Other1

Most cited: 21 CFR 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Non-pharmaceutical grade components are used in the formulation…

  2. 02

    Hazardous drugs were produced without providing adequate cleaning of work surfaces and/or cleaning of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Kohana Pharmacy and Center for Regenerative Medicine Inc.?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.67 (equipment cleaning and maintenance). The opening words of each observation are shown on this page.

Who inspected Kohana Pharmacy and Center for Regenerative Medicine Inc.?

Uttaniti Limchumroon is named on this Form 483, for the inspection of Apr 10 – Apr 17, 2019. Each investigator has a profile showing what they cite most.

When was Kohana Pharmacy and Center for Regenerative Medicine Inc. inspected by FDA?

The inspection ran Apr 10 – Apr 17, 2019, and the Form 483 is dated April 17, 2019.

How do I get the full Form 483 for Kohana Pharmacy and Center for Regenerative Medicine Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free